The Latest Breaking News from FDA

The biotechnology industry is flourishing due to the recent breakthroughs in drug development, technological advancements, and strong governmental backing. Given this backdrop, promising biotech stocks Organogenesis Holdings (ORGO), Theratechnologies (THTX), and Vertex Pharmaceuticals (VRTX) could be solid buys to supercharge the portfolios. Read on….

Until recently, the Chinese manufacturer behind Elf Bar e-cigarettes was able to slip its products passed U.S. customs officials

A deadly outbreak of salmonella poisoning linked to contaminated whole and pre-cut cantaloupe continues to grow

Quaker Oats recalls over 40 breakfast favorites due to potential salmonella exposure. No reported illnesses yet. Check dates and stay safe!

As $50 billion in opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. Stocks this morning are mildly higher, with the S&P...

Explore the controversial role of ketamine, a drug with promising therapeutic uses and dangerous recreational potential, in the death of actor Matthew Perry.

The pharmaceutical industry's outlook looks promising, given robust healthcare spending worldwide and the rapid adoption of advanced digital technologies. Amid this, let’s find out if pharma stocks AbbVie (ABBV), Collegium Pharmaceutical (COLL), and Merck (MRK) are ideal buys now. Read on to know more….

Urinary tract infections have been a cause of chronic distress for generations of menopausal women. Campaigning journalist Kate Muir argues the problem could be halved if an alternative treatment to antibiotics is better understood. So why isn’t more being done?